Monthly Archives: January 2016

Analysts Have Conflicting Sentiments on These Technology Companies: Flextronics International (NASDAQ: FLEX), NetSuite Inc (NYSE: N), Western Digital Corp. (NASDAQ: WDC) and Kla-tencor (NASDAQ: KLAC)

Analysts have been eager to weigh in on the Technology sector with new ratings on Flextronics International (NASDAQ: FLEX), NetSuite Inc (NYSE: N), Western Digital Corp. (NASDAQ: WDC) and Kla-tencor (NASDAQ: KLAC). Flextronics International (NASDAQ: FLEX) Deutsche Bank analyst Sherri

Deutsche Bank Maintains a Hold Rating on Nextera Energy Partners

In a report issued on January 29, Jonathan Arnold from Deutsche Bank maintained a Hold rating on Nextera Energy Partners (NYSE: NEP), with a price target of $25. The company’s shares closed last Friday at $26.99. Nextera Energy Partners has

Werner Enterprises Receives a Buy from Deutsche Bank

Deutsche Bank analyst Robert Salmon maintained a Buy rating on Werner Enterprises (NASDAQ: WERN) on January 29 and set a price target of $29. The company’s shares closed last Friday at $24.15. Werner Enterprises has an analyst consensus of Moderate

Deutsche Bank Maintains a Hold Rating on Bemis Company

In a report issued on January 29, Debbie Jones from Deutsche Bank maintained a Hold rating on Bemis Company (NYSE: BMS), with a price target of $45. The company’s shares closed last Friday at $47.87, close to its 52-week high

Analysts Have Conflicting Sentiments on These Conglomerates Companies: Triumph Group Inc (NYSE: TGI) and Raytheon (NYSE: RTN)

Analysts have been eager to weigh in on the Conglomerates sector with new ratings on Triumph Group Inc (NYSE: TGI) and Raytheon (NYSE: RTN). Triumph Group Inc (NYSE: TGI) Deutsche Bank analyst Myles Walton maintained a Buy rating on Triumph

Analsts Offer Insights on Healthcare Companies: Abbott Laboratories (NYSE: ABT) and C.R. Bard (NYSE: BCR)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Abbott Laboratories (NYSE: ABT) and C.R. Bard (NYSE: BCR). Abbott Laboratories (NYSE: ABT) Deutsche Bank analyst Kristen Stewart maintained a Buy rating on